tm logo
PYRAMID DESIGN
REGISTERED

on 03 Aug 2021

Last Applicant/ Owned by

NOVARTIS AG

4002 Basel

CH

Serial Number

1955557 filed on 04th Apr 2019

Registration Number

TMA1105889 registered on 03rd Aug 2021

Registration expiry Date

03rd Aug 2031

Correspondent Address

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

PYRAMID DESIGN

Vienna Information


26 . 3 . 4

Several triangles, juxtaposed, joined or intersectingPlusieurs triangles, juxtaposés, accolés ou se coupant

26 . 3 . 23

Lines or bands forming an angle -- Note: Including chevrons and arrowheads formed by lines or bands.Lignes ou bandes formant un angle -- Note: Y compris les chevrons et les pointes de flèches formées par des lignes ou des bandes.

26 . 3 . 24

Triangles with dark surfaces or parts of surfacesTriangles avec surface ou partie de la surface foncée

26 . 5 . 1

One polygonUn polygone

26 . 5 . 10

Polygons containing one or more triangles or lines forming an anglePolygones contenant un ou plusieurs triangles ou des lignes formant un angle

26 . 5 . 24

Polygons with dark surfaces or parts of surfacesPolygones avec surface ou partie de la surface foncée

25 . 5 . 25

Other backgrounds divided into two or fourAutres fonds partagés en deux ou en quatre

26 . 5 . 26

Polygons with cutout areasPolygones avec des zones découpées

26 . 15 . 7

Pyramids (geometrical figures)Pyramides (figures géométriques)

26 . 15 . 15

Other polyhedronsAutres polyèdres

29 . 1 . 3

GreenVert

29 . 1 . 4

BlueBleu

29 . 1 . 2

Yellow, goldJaune, or

29 . 1 . 6

White, grey, silverBlanc, gris, argent

Trademark usage description

pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, Read More

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue disease, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; anti-infectives, anti-bacterials, antivirals, anti-biotics, systemic and topical anti-fungals


Classification kind code

11

Mark Details


Serial Number

1955557

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 190
on 23rd Jun 2021
Registration Pending
Submitted for opposition 42
on 31st Mar 2021
Advertised
Submitted for opposition 26
on 08th Mar 2021
Approved
Submitted for opposition 27
on 08th Mar 2021
Approval Notice Sent
Submitted for opposition 22
on 23rd Oct 2019
Search Recorded
Submitted for opposition 20
on 23rd Oct 2019
Examiner's First Report
Submitted for opposition 67
on 11th Sep 2019
Agent Name Changed
Submitted for opposition 31
on 09th Apr 2019
Formalized
Submitted for opposition 1
on 05th Apr 2019
Created
Submitted for opposition 30
on 04th Apr 2019
Filed